NEDO
VC Fund
Kawasaki, Japan
NEDO is a VC fund in Kawasaki focused on Medical and Health Care. New Energy and Industrial Technology Development Organization (NEDO) was established as a governmental organization in 1980 to promote the development and introduction of new energy technologies. Research and development of industrial technology was later added, and today NEDO is active in a wide variety of areas as one of the largest publicresearch and development management organizations in Japan.
- Total investments:
- 41
- Last investment:
- Lead investor:
- 59%
Last updated:
For AI agents: llms.txt
Industries NEDO invests in
Stages NEDO invests in
Countries NEDO invests in
Round sizes
Round size
- Seed
- $885k–$991k
- Grant
- $1.7M–$26M
- Series A
- $800k–$4.7M
Investment Focus
Industry
- Medical 13 (32%)
- Health Care 13 (32%)
- Biotechnology 9 (22%)
- Manufacturing 8 (20%)
- Medical Device 6 (15%)
Stage
- Grant 25 (61%)
- Series A 5 (12%)
- Seed 3 (7%)
- Series B 2 (5%)
- Funding Round 1 (2%)
Country
- Japan 33 (80%)
- United States 1 (2%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| TASKAJI is an online housekeeping service that matches people looking for someone to do their housekeeping with those who want to work as housekeepers.The companies motto is of “from the nuclear family to the extended family” and it aims to provide people with more leisure time through its concept of “housekeeping sharing. | Grant / Sep 30, 2026 | ||
| SolaNika mission is to shackle energy with laser wireless power transfer and accelerate human progress. | Grant / Sep 24, 2026 | ||
| Quixotiks develops research-driven AI systems utilizing cognitive neuropsychology algorithms to simulate expert communication styles. The company provides automated dialogue integration and localized large language model consulting to assist healthcare, welfare, and corporate sectors. | Grant / Aug 20, 2026 | ||
| BiPSEE is a medical XR company that provides treatment support for children for the purpose of nurturing a sense of self-efficacy. They also deploy AR and VR animation with one button dentistry and medicine, whether outpatient or hospitalized in various situations your child's anxiety and pain relieve. It aims to reduce anxiety and pain inchildren in a wide range of medical fields such as dentistry, pediatrics, and dermatology.BiPSEE is abs ed in Tokyo, Japan. | Grant / Aug 17, 2026 | ||
| Asist is a startup specializing in data-driven scientific solutions, supporting data analysis and research optimization. | Grant / Jul 22, 2026 | ||
| SONIRE Therapeutics Inc. (SONIRE) is working on a next-generation high-intensity focused ultrasound (HIFU) therapy system that will employ acoustic engineering (ultrasound) technologies developed through cutting-edge academic research. SONIRE has been working on a next-generation high-intensity focused ultrasound (HIFU) treatment system as a noveltherapeutic modality with the goal of giving cancer patients and their families a new future. | $13M / Grant / Jun 17, 2026 | ||
| BitBiome is a biotechnology company focused on analyzing microbial genomes and discovering enzymes and proteins that can be applied across industries such as pharmaceuticals, food production, and sustainable manufacturing. The company uses single-cell microbial sequencing technology to study microbes that are difficult to culture throughconventional laboratory methods, enabling the creation of a large microbial genome database called bit-GEM. Its platform supports enzyme discovery, genome analysis, and bioengineering efforts aimed at developing bio-based alternatives for industrial processes. bitBiome also works with academic institutions and commercial partners on research projects involving areas such as biodegradable materials, biomass conversion, and pharmaceutical ingredient synthesis. The company positions microbes as a resource for advancing the bioeconomy by providing tools and data that support biotechnology research and industrial applications. | Grant / May 26, 2026 | ||
| GramEye is a developer of medical equipment that uses robotics and deep learning to automate gram staining. The company operates under the assumption that the growth of germs that are resistant to antibiotics is a natural occurrence brought on by the usage of these medications. It aspires to a world in which antibiotics are correctly prescribed inall medical contexts. GramEye analyzes medical data, create web services, and create mobile applications as a health sciences company. | $2.7M / Grant / Nov 21, 2025 | ||
| Boston Medical Sciences conducts research, prevention, and diagnostics procedures to eliminate colorectal cancer deaths. | Grant / Sep 18, 2025 | ||
| Fermelanta produces rare plant-based ingredients through microbial fermentation. It engineers a cell to build a biosynthetic pathway of target molecules with gene transfer and disruption. | Grant / Aug 29, 2025 | ||
| See all 41 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does NEDO invest in?
NEDO invests primarily in Medical, Health Care and Biotechnology startups, most often at Grant and Series A stage. Most of the 41 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is NEDO's check size?
NEDO typically joins rounds of $885k–$991k at Seed, $1.7M–$26M at Grant and $800k–$4.7M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds NEDO participates in.
When did NEDO last invest?
The most recent investment recorded for NEDO closed in Sep 2026. Shizune tracks 41 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
